Sourcing Exosomes in Iowa
Licensed Iowa practices order Kimera exosome material from ExaVeyra for topical aesthetic use, shipped frozen from Florida with a Certificate of Analysis and lot traceability on every vial. Iowa buyers need their own professional license and NPI; the wholesale distributor license is the supplier’s obligation, not the purchaser’s.
Iowa is one of the easier states to map. Advanced registered nurse practitioners hold full practice authority, physician assistant collaboration is set at the practice level rather than in a filed agreement, and every board involved sits inside a single agency, the Department of Inspections, Appeals, and Licensing.
At a glance
| Question | Answer |
|---|---|
| Does ExaVeyra ship to Iowa? | Yes. Shipped frozen from Florida, as we do to all 50 states |
| Cold-chain shipping from Florida | Overnight shipping; arrival can take 1 to 3 business days |
| State regenerative-medicine statute | None |
| Does that statute reach exosomes? | No. Its definition is written around cells; exosomes are acellular and governed federally |
| Physician delegation required to hand off medical acts | Yes |
| Who holds the licensure to ship into the state | The pharmacy partner and the tissue bank that ship, not the purchasing practice |
| What ExaVeyra supplies here | Kimera exosome material; compounded preparations available through the 503A pharmacy partner |
| Last reviewed | 16 October 2026 |
Ordering from Iowa
ExaVeyra ships to licensed practices in all 50 states, Iowa included. Licensure for shipping into the state is held by the entities that ship: our 503A pharmacy partner holds nonresident pharmacy licenses in 33 jurisdictions, including Puerto Rico, and exosome material ships from a registered tissue bank licensed to ship to all 50 states and Puerto Rico. Your practice orders against its own professional license and NPI and needs no wholesale permit to purchase.
What your practice provides
- An active Iowa professional license in good standing, verifiable through the Department of Inspections, Appeals, and Licensing public license search.
- A valid NPI, which ExaVeyra verifies at account setup.
- A signed professional-use acknowledgment on file for exosome material.
- An Iowa sales tax permit and exemption certificate through the Iowa Department of Revenue if the practice is purchasing for resale rather than for use in its own operations.
How the state permits wholesale distribution
Iowa licenses any wholesaler, regardless of location, that distributes prescription drugs into, out of, or within the state, through the Board of Pharmacy inside the Department of Inspections, Appeals, and Licensing. Iowa Code 155A.17 ties the license expressly to the federal Drug Supply Chain Security Act: distributors must comply with the national DSCSA standards, and the board’s rules are written to stay consistent with them. Licenses run per physical location and expire each December 31. The license sits with the distributor, not with the purchasing practice.
Iowa Code § 155A.17; 481 Iowa Admin. Code chs. 551, 554 · Iowa Board of Pharmacy (Department of Inspections, Appeals, and Licensing)
Iowa regenerative-medicine law
Iowa has not enacted a statute specific to stem cell or regenerative therapies. Practice in this area is governed by the state's general medical practice and professional licensing rules, alongside federal law.
Iowa has a stem cell chapter on its books, and it is regularly mistaken for a practice law. Chapter 707C of the Iowa Code, enacted in 2007 as the Iowa Stem Cell Research and Cures Initiative, states a purpose of ensuring that Iowa patients have access to stem cell therapies and that Iowa researchers may conduct stem cell research, and then spends its operative sections prohibiting human reproductive cloning, with felony penalties. It neither authorizes nor conditions any clinical service. No Iowa statute addresses unapproved regenerative therapy, so practice in this area is governed by the Medical Practice Act, the Nurse Practice Act, and the boards that administer them, alongside federal law.
How this applies to exosomes
Iowa has not enacted a stem cell authorization law like Florida, Texas, or Georgia, a disclosure law like California, or a documentation statute like Tennessee. Chapter 707C, the Iowa Stem Cell Research and Cures Initiative, is sometimes cited as though it authorized stem cell treatment; its operative provisions prohibit human reproductive cloning and authorize nothing clinical. There is therefore no Iowa definition to read exosomes into or out of, and exosomes are acellular extracellular vesicles in any case, outside the cell-focused language such statutes use. Exosome products in Iowa are governed by federal law, under which no exosome product has been approved by the FDA for administration to humans. ExaVeyra supplies Kimera material for topical aesthetic use by licensed practitioners, with full COA and lot documentation.
Who can handle product in a Iowa practice
Because ARNPs hold independent authority and PA collaboration is set at the practice level, Iowa supports both ARNP-led and physician-led structures. A medical director is still the practical norm for delegated aesthetic procedures, and is needed where a procedure falls outside ARNP scope or where a payer requires one. All the professions here are licensed through the Department of Inspections, Appeals, and Licensing, so verification runs through a single agency.
| Role | Scope under state law |
|---|---|
| MD / DO | Physicians licensed by the Iowa Board of Medicine under Iowa Code chapters 147 and 148 may perform medical acts within their scope and are the source of any delegation to staff who do not hold independent authority. |
| NP / APRN | Iowa is a full practice authority state. Advanced registered nurse practitioners are licensed by the Board of Nursing alone, practice without a required collaborative or supervisory agreement with a physician, and prescribe within their role and population focus under the board’s advanced practice rules. |
| PA | Physician assistants may provide any legal medical service they are prepared for by education, training, or experience and are competent to perform, under Iowa Code 148C.4. Since the 2020 amendments, the degree of collaboration between a PA and the health care team is determined at the practice level, by the medical group, supervising physician, employer, or facility credentialing system, rather than in a state-filed agreement. |
| RN | Registered nurses practice under Iowa Code 152.1, which includes executing a regimen prescribed by a physician, an advanced registered nurse practitioner, or a physician assistant. An RN administers delegated treatments under such an order and does not evaluate the patient or select the treatment. |
Good faith examination
Iowa expects a patient evaluation by a provider with authority to conduct it, and an order, before a delegated treatment is administered. Where an advanced registered nurse practitioner holds independent authority, that provider can be the ARNP. Confirm current expectations with the Iowa Board of Medicine and the Iowa Board of Nursing, since this area is governed by board interpretation rather than a single statute.
Ownership and clinic licensing
Iowa does not codify a corporate practice of medicine prohibition of the Texas or New York kind. Professional corporations and management services arrangements are the usual structures, and the boards still expect clinical decisions to sit with licensed clinicians. Because the position rests on general professional-entity law rather than a bright-line statute, treat ownership structure as a question for Iowa counsel rather than one a guide should answer with a percentage.
Cold chain into Iowa
Shipments leave Florida frozen under validated temperature monitoring. A package in transit over a weekend waits in the carrier network, so practices in Iowa order around weekend and holiday closures.
| Metro | County | Notes |
|---|---|---|
| Des Moines | Polk | Largest Iowa market, anchoring the central corridor. |
| West Des Moines | Polk | Western metro suburb with a concentration of aesthetic practices. |
| Iowa City | Johnson | Academic medical hub around the University of Iowa. |
| Cedar Rapids | Linn | Second largest city, served on the same eastern Iowa lane as Iowa City. |
| Davenport | Scott | Quad Cities market on the Illinois border. |
| Sioux City | Woodbury | Northwest Iowa market serving the tri-state corner. |
- Iowa orders of fifteen or more cold-chain units ship free nationwide; see the volume program for current thresholds.
- Every vial arrives with the manufacturer’s handling instructions and the Certificate of Analysis for its lot, and storage on arrival follows those instructions.
Practice types we supply in Iowa
Iowa licensing and verification
Iowa Board of Medicine (DIAL)
Physician licensing sits inside the Department of Inspections, Appeals, and Licensing since 2023.
Iowa Board of Nursing (DIAL)
Licenses RNs and ARNPs; ARNPs practice with full practice authority.
Iowa Board of Pharmacy (DIAL)
Issues the wholesale distributor license under Iowa Code 155A.17.
Iowa Board of Pharmacy, Wholesale Distributor Licensure
Iowa Department of Revenue
Sales tax permits and exemption certificates.
Iowa sourcing questions
- Does Iowa have a stem cell law?
- Not a practice law. Chapter 707C of the Iowa Code, the Iowa Stem Cell Research and Cures Initiative of 2007, states a purpose of supporting stem cell research and access, and its operative sections prohibit human reproductive cloning. It authorizes no clinical service, so it is regularly miscited. Iowa has no stem cell authorization law, disclosure law, or documentation statute, and exosome products there are governed by federal law.
- Are exosomes FDA approved?
- No. The FDA stated in its 2019 public safety notification that there are no FDA-approved exosome products, and that remains the case. ExaVeyra supplies Kimera exosome material for topical aesthetic use by licensed practitioners, with a Certificate of Analysis and lot documentation on every vial.
- Can an ARNP run a practice in Iowa without a physician?
- Iowa is a full practice authority state. Advanced registered nurse practitioners are licensed by the Board of Nursing alone and practice without a required collaborative or supervisory agreement, evaluating and ordering within their role and population focus. A medical director is still needed where a procedure falls outside ARNP scope or where a payer requires one.
- What changed for Iowa physician assistants?
- Iowa Code 148C.4 was amended in 2020 so that the degree of collaboration between a physician assistant and the health care team is determined at the practice level, by the medical group, supervising physician, employer, or facility credentialing system, rather than through a state-filed supervision agreement. A PA may provide any legal medical service they are prepared for and competent to perform.
- Does my Iowa clinic need a wholesale distributor license to buy exosomes?
- No. The wholesale distributor license under Iowa Code 155A.17 is held by the distributor shipping into Iowa, not by the practice buying. Your practice orders against its own professional license and NPI. Licensure for shipping into the state is held by the entities that ship: our 503A pharmacy partner for compounded preparations, and a registered tissue bank licensed to ship to all 50 states and Puerto Rico for exosome material.
- How long does cold-chain shipping take to Iowa?
- Ships from Florida by overnight shipping, and arrival can take one to three business days. All exosome shipments travel cold-chain with validated temperature monitoring. A shipment in transit over a weekend waits in the carrier network, so a practice that will be closed orders around the closure.
Sources
Last reviewed 16 October 2026 by ExaVeyra Sciences editorial team. Every claim above links to a primary source.
- Iowa Board of Pharmacy (DIAL), wholesale distributor licensure (accessed 16 October 2026)
- Iowa Code 155A.17, wholesale distributor license (accessed 16 October 2026)
- Iowa Code chapter 707C, human stem cell research and cloning (accessed 16 October 2026)
- Iowa Code 152.1, nursing definitions (accessed 16 October 2026)
- Iowa Code 148C.4, services performed by physician assistants (accessed 16 October 2026)
- Iowa DIAL, nursing and professional midwifery licensing (accessed 16 October 2026)
- Iowa Department of Revenue (accessed 16 October 2026)
- FDA Public Safety Notification on Exosome Products (accessed 16 October 2026)
Scientific literature
Peer-reviewed references, each with its study design and, for human studies, the number of participants, so a reader can judge the weight of a citation without opening it. None is a claim about any product.
- Welsh JA, Goberdhan DCI, O’Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles, 2024. doi:10.1002/jev2.12404 PMID:38326288Clinical guidelinesupports: Defines the field’s current characterization and reporting standard for extracellular vesicles, the benchmark behind the COA and lot documentation this Iowa guide describes.
- Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 2018. doi:10.1080/20013078.2018.1535750 PMID:30637094Clinical guidelinesupports: The landmark EV characterization standard that MISEV2023 updates; together they define what a complete exosome characterization package on a supplier COA contains.
- Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. Journal of Extracellular Vesicles, 2015. doi:10.3402/jev.v4.30087 PMID:26725829Consensus statementsupports: ISEV position on manufacturing and safety documentation for EV-based products in trials, supporting this page’s framing that clinical use of exosomes runs through regulated research rather than any Iowa statute.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Biomolecular signaling vesicle products distributed by ExaVeyra Sciences are supplied for topical aesthetic use by licensed practitioners and for laboratory and IND-authorized clinical research, and are not tissue products as defined by FDA guidelines.